Researchers at the Center for Algorithmic and Robotized Synthesis within the Institute for Basic Science have taken a significant step forward in understanding the stability of proteins by leveraging the power of AI. The research team used AlphaFold2 to explore how mutations affect protein stability-; a crucial factor in ensuring proteins function correctly and do not cause diseases like Alzheimer’s.
Merck KGaA makes $600M bet to boost manufacturing for viral vectors
Merck KGaA announced Wednesday that it is acquiring Mirus Bio, a startup that develops transfection reagents for viral cell and gene therapies, for $600 million.